Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
JMP Securities healthcare analysts hold an analyst/industry conference call » 12:36
07/08/24
07/08
12:36
07/08/24
12:36
HOOK

Hookipa Pharma

/

+

, INO

Inovio

$8.88 /

-0.04 (-0.45%)

, PGEN

Precigen

$1.55 /

+0.12 (+8.39%)

, CUE

Cue Biopharma

/

+

, PDSB

PDS Biotechnology

$3.14 /

+0.01 (+0.32%)

, MRUS

Merus

$55.11 /

+1.765 (+3.31%)

Healthcare Analysts…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Over a month ago
Hot Stocks
Cue Biopharma presents updated data from Phase 1 trial of CUE-101 » 08:14
06/04/24
06/04
08:14
06/04/24
08:14
CUE

Cue Biopharma

$1.66 /

+0.04 (+2.47%)

Cue Biopharma announced…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Cue Biopharma reports Q1 EPS (25c), consensus (28c) » 16:42
05/09/24
05/09
16:42
05/09/24
16:42
CUE

Cue Biopharma

$1.92 /

+0.005 (+0.26%)

Reports Q1 revenue $1.7M,…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Over a quarter ago
On The Fly
Biotech Alert: Searches spiking for these stocks today » 11:20
04/11/24
04/11
11:20
04/11/24
11:20
PTN

Palatin

$1.92 /

+0.04 (+2.13%)

, LPTX

Leap Therapeutics

$3.96 /

+0.91 (+29.84%)

, BCLI

BrainStorm

/

+

, SAVA

Cassava Sciences

$26.27 /

+1.75 (+7.14%)

, EYEN

Eyenovia

/

+

, CUE

Cue Biopharma

$1.67 /

-0.11 (-6.18%)

, MTEM

Molecular Templates

$1.77 /

-0.06 (-3.28%)

, VBIV

VBI Vaccines

/

+

, SYRS

Syros Pharmaceuticals

$5.52 /

-0.025 (-0.45%)

, ALKS

Alkermes

$25.75 /

-0.385 (-1.47%)

 
Initiation
Cue Biopharma initiated with bullish view at Jefferies, here's why » 04:58
03/13/24
03/13
04:58
03/13/24
04:58
CUE

Cue Biopharma

$1.77 /

-0.13 (-6.84%)

Jefferies analyst Maury…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Cue Biopharma presenting data on lead clinical asset CUE-101 at symposium » 10:04
02/29/24
02/29
10:04
02/29/24
10:04
CUE

Cue Biopharma

$2.16 /

+0.045 (+2.13%)

Cue Biopharma announced…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Cue Biopharma reports Q3 EPS (24c), consensus (34c) » 16:17
11/09/23
11/09
16:17
11/09/23
16:17
CUE

Cue Biopharma

$2.08 /

-0.235 (-10.17%)

Reports Q3 collaboration…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Cue Biopharma presents data from Phase 1 trials of CUE-101 » 12:13
11/03/23
11/03
12:13
11/03/23
12:13
CUE

Cue Biopharma

$2.42 /

+0.21 (+9.50%)

Cue Biopharma announced…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Cue Biopharma completes patient enrollment in Phase 1b study of CUE-101 » 08:13
09/26/23
09/26
08:13
09/26/23
08:13
CUE

Cue Biopharma

$2.24 /

-0.055 (-2.40%)

Cue Biopharma announced…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Cue Biopharma sees cash, securities funding operations through Q3 of 2024 » 16:27
08/09/23
08/09
16:27
08/09/23
16:27
CUE

Cue Biopharma

$3.63 /

+0.055 (+1.54%)

As of June 30, the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Cue Biopharma reports Q2 EPS (29c), consensus (34c) » 16:26
08/09/23
08/09
16:26
08/09/23
16:26
CUE

Cue Biopharma

$3.63 /

+0.055 (+1.54%)

Reports Q2 revenue…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.